Breaking News Instant updates and real-time market news.

PCH

PotlatchDeltic

$51.65 /

-0.02 (-0.04%)

17:00
07/22/21
07/22
17:00
07/22/21
17:00

PotlatchDeltic announces temporary closure of public access in Idaho

The company stated, "PotlatchDeltic announced changes to public access to its Idaho timberlands. Due to severe fire danger in the region, effective immediately and until further notice, all public use of PotlatchDeltic privately-owned timberlands for recreation is suspended. The extreme fire season and continued dry conditions in Idaho are stressing available firefighting resources and risking public safety, property, and impacting wildlife. As a result, PotlatchDeltic has taken the unusual step of closing public access to its ownership areas, including the use of PotlatchDeltic roads and walk-in access. Leased campsites must be vacated before August 1, 2021. The temporary closure is permitted under the access terms in the Idaho Department of Fish and Game's Large Tracts Program. Several other area landowners who participate in the Program have also recently suspended access due to the excessive fire danger. PotlatchDeltic continues to believe that managing our lands and allowing others to enjoy them are not mutually exclusive and that the majority of our lands should be available to the public for a wide range of uses. We look forward to removing the Idaho closure once fire conditions have abated. PotlatchDeltic urges all visitors to Idaho's forests to exercise extreme caution in regards to fire while recreating this summer."

  • 27

    Jul

PCH PotlatchDeltic
$51.65 /

-0.02 (-0.04%)

04/28/21 RBC Capital
PotlatchDeltic downgraded to Sector Perform from Outperform at RBC Capital
04/27/21 BMO Capital
PotlatchDeltic downgraded to Market Perform from Outperform at BMO Capital
04/26/21 Raymond James
PotlatchDeltic price target raised to $79 from $61 at Raymond James
03/17/21 DA Davidson
PotlatchDeltic cut to Neutral at DA Davidson on valuation

TODAY'S FREE FLY STORIES

Hot Stocks
Brown & Brown announces asset acquisition of AGIS Network » 06:33
09/20/21
09/20
06:33
09/20/21
06:33
BRO

Brown & Brown

$56.96 /

-0.495 (-0.86%)

Brown & Brown and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

08/16/21 Wolfe Research
Brown & Brown initiated with a Peer Perform at Wolfe Research
07/27/21 Keefe Bruyette
Keefe Bruyette boosts Brown & Brown target on 'stronger' organic growth
04/28/21 Deutsche Bank
Brown & Brown price target raised to $55 from $50 at Deutsche Bank
04/28/21 RBC Capital
Brown & Brown price target raised to $53 from $48 at RBC Capital
BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

BRO Brown & Brown
$56.96 /

-0.495 (-0.86%)

Hot Stocks
Brooks Automation to sell semiconductor solutions group business for $3B » 06:32
09/20/21
09/20
06:32
09/20/21
06:32
BRKS

Brooks Automation

$94.21 /

+1.46 (+1.57%)

Brooks Automation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

09/07/21 KeyBanc
Brooks Automation price target raised to $146 from $115 at KeyBanc
05/11/21 Needham
Brooks Automation price target raised to $130 from $110 at Needham
05/11/21 Credit Suisse
Brooks Automation price target raised to $85 from $70 at Credit Suisse
05/11/21 B. Riley
Brooks Automation price target raised to $130 from $125 at B. Riley
BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

Hot Stocks
Thomas H. Lee to acquire automation business from Brooks Automation for $3B » 06:32
09/20/21
09/20
06:32
09/20/21
06:32
BRKS

Brooks Automation

$94.21 /

+1.46 (+1.57%)

Thomas H. Lee Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

09/07/21 KeyBanc
Brooks Automation price target raised to $146 from $115 at KeyBanc
05/11/21 Needham
Brooks Automation price target raised to $130 from $110 at Needham
05/11/21 Credit Suisse
Brooks Automation price target raised to $85 from $70 at Credit Suisse
05/11/21 B. Riley
Brooks Automation price target raised to $130 from $125 at B. Riley
BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

BRKS Brooks Automation
$94.21 /

+1.46 (+1.57%)

Recommendations
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote » 06:31
09/20/21
09/20
06:31
09/20/21
06:31
PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, AZN

AstraZeneca

$55.56 /

-1.04 (-1.84%)

, ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, NVO

Novo Nordisk

$101.45 /

-0.945 (-0.92%)

, SNY

Sanofi

$48.35 /

+0.14 (+0.29%)

Despite Friday's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

09/17/21 Evercore ISI
Innate Pharma price target raised to $10 from $6 at Evercore ISI
09/17/21 Morgan Stanley
AstraZeneca price target raised to 10,000 GBp from 9,800 GBp at Morgan Stanley
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

09/03/21 Berenberg
Novo Nordisk price target raised to DKK 530 from DKK 430 at Berenberg
08/23/21 Credit Suisse
Novo Nordisk price target raised to DKK 625 from DKK 470 at Credit Suisse
08/23/21 Citi
Novo Nordisk price target raised to DKK 780 from DKK 510 at Citi
08/17/21 UBS
Novo Nordisk price target raised to DKK 630 from DKK 447 at UBS
SNY Sanofi
$48.35 /

+0.14 (+0.29%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

NVO Novo Nordisk
$101.45 /

-0.945 (-0.92%)

SNY Sanofi
$48.35 /

+0.14 (+0.29%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

General news
FOMC forecasts » 06:30
09/20/21
09/20
06:30
09/20/21
06:30
$ECON

Economic Data

/

+

FOMC forecasts to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Eros STX Global bondholders approve amendment to extend maturity date » 06:29
09/20/21
09/20
06:29
09/20/21
06:29
ESGC

Eros STX Global

/

+

Eros STX Global announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESGC Eros STX Global
/

+

ESGC Eros STX Global
/

+

ESGC Eros STX Global
/

+

Recommendations
NRG Energy removed from US 1 List at BofA  06:27
09/20/21
09/20
06:27
09/20/21
06:27
NRG

NRG Energy

$42.07 /

-0.93 (-2.16%)

 
ShowHide Related Items >><<
NRG NRG Energy
$42.07 /

-0.93 (-2.16%)

NRG NRG Energy
$42.07 /

-0.93 (-2.16%)

06/27/21 Goldman Sachs
NRG Energy upgraded to Conviction Buy from Buy at Goldman Sachs
06/21/21 Seaport Global
NRG Energy price target raised to $47 from $42 at Seaport Global
03/18/21
Fly Intel: Top five analyst downgrades
03/18/21 Morgan Stanley
NRG Energy price target lowered to $51 from $59 at Morgan Stanley
NRG NRG Energy
$42.07 /

-0.93 (-2.16%)

NRG NRG Energy
$42.07 /

-0.93 (-2.16%)

Hot Stocks
SmileDirectClub up 15% in pre-market trading at $7.71 per share » 06:27
09/20/21
09/20
06:27
09/20/21
06:27
SDC

SmileDirectClub

$6.70 /

+0.705 (+11.76%)

Shares of SmileDirectClub…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

08/13/21
Fly Intel: Top five analyst downgrades
08/13/21 Wolfe Research
SmileDirectClub downgraded to Peer Perform from Outperform at Wolfe Research
08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 Loop Capital
SmileDirectClub price target lowered to $6 from $9 at Loop Capital
SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

SDC SmileDirectClub
$6.70 /

+0.705 (+11.76%)

Recommendations
Adobe shares may be pricing in front office tailwinds, says Citi » 06:26
09/20/21
09/20
06:26
09/20/21
06:26
ADBE

Adobe

$655.09 /

-10.26 (-1.54%)

Citi analyst Tyler Radke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

09/17/21 Mizuho
Adobe price target raised to $695 from $640 at Mizuho
09/16/21 BMO Capital
Adobe price target raised to $730 from $630 at BMO Capital
09/16/21 Barclays
Adobe price target raised to $740 from $660 at Barclays
09/15/21 Morgan Stanley
Adobe price target raised to $736 from $610 at Morgan Stanley
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

Hot Stocks
Rocky Mountain Chocolate sends letter to stockholders » 06:24
09/20/21
09/20
06:24
09/20/21
06:24
RMCF

Rocky Mountain Chocolate

$7.80 /

+ (+0.00%)

Rocky Mountain Chocolate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RMCF Rocky Mountain Chocolate
$7.80 /

+ (+0.00%)

Initiation
i-80 Gold initiated with an Outperform at RBC Capital » 06:23
09/20/21
09/20
06:23
09/20/21
06:23
IAUCF

i-80 Gold

$2.38 /

-0.02 (-0.83%)

RBC Capital analyst Wayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAUCF i-80 Gold
$2.38 /

-0.02 (-0.83%)

IAUCF i-80 Gold
$2.38 /

-0.02 (-0.83%)

09/08/21 Canaccord
i-80 Gold price target raised to C$5.50 from C$3.75 at Canaccord
09/08/21 Scotiabank
i-80 Gold price target raised to C$4.25 from C$3.75 at Scotiabank
05/20/21 Stifel
i-80 Gold initiated with a Buy at Stifel
05/12/21 Canaccord
i-80 Gold initiated with a Buy at Canaccord
Recommendations
TCR2 Therapeutics price target lowered to $25 from $37 at H.C. Wainwright » 06:23
09/20/21
09/20
06:23
09/20/21
06:23
TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

  • 20
    Jan
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

Upgrade
Credit Suisse upgrades 'compelling' Acadia Healthcare on recent selloff » 06:21
09/20/21
09/20
06:21
09/20/21
06:21
ACHC

Acadia Healthcare

$61.18 /

+1.87 (+3.15%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACHC Acadia Healthcare
$61.18 /

+1.87 (+3.15%)

ACHC Acadia Healthcare
$61.18 /

+1.87 (+3.15%)

06:06 Today Credit Suisse
Acadia Healthcare upgraded to Outperform from Neutral at Credit Suisse
09/09/21 Cowen
Acadia Healthcare organic growth accelerating, says Cowen
09/09/21 Cowen
Acadia Healthcare initiated with an Outperform at Cowen
08/12/21 Barclays
Acadia Healthcare initiated with an Underweight at Barclays
ACHC Acadia Healthcare
$61.18 /

+1.87 (+3.15%)

Downgrade
Itamar Medical downgraded to Market Perform from Outperform at SVB Leerink » 06:18
09/20/21
09/20
06:18
09/20/21
06:18
ITMR

Itamar Medical

$30.28 /

-0.04 (-0.13%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITMR Itamar Medical
$30.28 /

-0.04 (-0.13%)

ITMR Itamar Medical
$30.28 /

-0.04 (-0.13%)

09/15/21
Fly Intel: Top five analyst downgrades
09/15/21 Ladenburg
Itamar Medical downgraded to Neutral from Buy at Ladenburg
09/14/21 Alliance Global Partners
Itamar Medical downgraded to Neutral from Buy at Alliance Global Partners
09/14/21 H.C. Wainwright
Itamar Medical downgraded to Neutral from Buy at H.C. Wainwright
ITMR Itamar Medical
$30.28 /

-0.04 (-0.13%)

  • 05
    Feb
ITMR Itamar Medical
$30.28 /

-0.04 (-0.13%)

Initiation
Tango Therapeutics initiated with an Outperform at SVB Leerink » 06:18
09/20/21
09/20
06:18
09/20/21
06:18
TNGX

Tango Therapeutics

$17.23 /

+0.385 (+2.29%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNGX Tango Therapeutics
$17.23 /

+0.385 (+2.29%)

TNGX Tango Therapeutics
$17.23 /

+0.385 (+2.29%)

09/07/21
Fly Intel: Top five analyst initiations
09/07/21 Wedbush
Tango Therapeutics initiated with an Outperform at Wedbush
09/07/21 Guggenheim
Tango Therapeutics initiated with a Buy at Guggenheim
09/07/21 Goldman Sachs
Tango Therapeutics initiated with a Buy at Goldman Sachs
Downgrade
ASM International downgraded to Equal Weight from Overweight at Barclays » 06:16
09/20/21
09/20
06:16
09/20/21
06:16
ASMIY

ASM International

$433.40 /

-12.07 (-2.71%)

Barclays analyst Keegan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASMIY ASM International
$433.40 /

-12.07 (-2.71%)

ASMIY ASM International
$433.40 /

-12.07 (-2.71%)

09/16/21 JPMorgan
ASM International price target raised to EUR 438 from EUR 345 at JPMorgan
09/10/21 AlphaValue/Baader
ASM International upgraded to Add from Reduce at AlphaValue/Baader
09/08/21 Berenberg
ASM International price target raised to EUR 400 from EUR 350 at Berenberg
08/05/21 JPMorgan
ASM International price target raised to EUR 345 from EUR 315 at JPMorgan
ASMIY ASM International
$433.40 /

-12.07 (-2.71%)

ASMIY ASM International
$433.40 /

-12.07 (-2.71%)

Hot Stocks
Verastem jumps 27% to $3.50 per share after data on VS-6766 in ovarian cancer  06:16
09/20/21
09/20
06:16
09/20/21
06:16
VSTM

Verastem

$2.76 /

+0.06 (+2.23%)

 
ShowHide Related Items >><<
VSTM Verastem
$2.76 /

+0.06 (+2.23%)

VSTM Verastem
$2.76 /

+0.06 (+2.23%)

07/01/21 Alliance Global Partners
Verastem initiated with a Buy at Alliance Global Partners
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
VSTM Verastem
$2.76 /

+0.06 (+2.23%)

VSTM Verastem
$2.76 /

+0.06 (+2.23%)

Periodicals
Universal Music to debut of Amsterdam Euronext stock exchange, WSJ reports » 06:14
09/20/21
09/20
06:14
09/20/21
06:14
VIVHY

Vivendi

$37.35 /

-0.12 (-0.32%)

Vivendi's spinoff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIVHY Vivendi
$37.35 /

-0.12 (-0.32%)

VIVHY Vivendi
$37.35 /

-0.12 (-0.32%)

09/16/21 Exane BNP Paribas
Lagardere upgraded to Neutral from Underperform at Exane BNP Paribas
08/26/21 UBS
Vivendi price target raised to EUR 41 from EUR 38 at UBS
08/26/21 JPMorgan
Vivendi price target raised to EUR 45 from EUR 44 at JPMorgan
08/26/21 Barclays
Vivendi upgraded to Overweight from Equal Weight at Barclays
VIVHY Vivendi
$37.35 /

-0.12 (-0.32%)

VIVHY Vivendi
$37.35 /

-0.12 (-0.32%)

Downgrade
Anglo American downgraded to Equal Weight from Overweight at Barclays » 06:14
09/20/21
09/20
06:14
09/20/21
06:14
NGLOY

Anglo American

$18.06 /

-1.5899 (-8.09%)

Barclays analyst Ian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGLOY Anglo American
$18.06 /

-1.5899 (-8.09%)

NGLOY Anglo American
$18.06 /

-1.5899 (-8.09%)

04:41 Today Berenberg
BHP Group downgraded to Hold from Buy at Berenberg
09/17/21 Morgan Stanley
Anglo American downgraded to Equal Weight from Overweight at Morgan Stanley
09/17/21 UBS
Anglo American downgraded to Sell from Neutral at UBS
09/16/21 Deutsche Bank
Anglo American price target lowered to 3,600 GBp at Deutsche Bank
NGLOY Anglo American
$18.06 /

-1.5899 (-8.09%)

Periodicals
Facebook leaders worry whether platform has gotten 'too big,' WSJ reports » 06:14
09/20/21
09/20
06:14
09/20/21
06:14
FB

Facebook

$364.61 /

-8.48 (-2.27%)

A meeting of Facebook…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$364.61 /

-8.48 (-2.27%)

FB Facebook
$364.61 /

-8.48 (-2.27%)

09/17/21 Jefferies
Facebook price target raised to $440 from $425 at Jefferies
09/13/21 Goldman Sachs
Facebook initiated with a Buy at Goldman Sachs
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
09/09/21 HSBC
Facebook price target raised to $300 from $275 at HSBC
FB Facebook
$364.61 /

-8.48 (-2.27%)

FB Facebook
$364.61 /

-8.48 (-2.27%)

FB Facebook
$364.61 /

-8.48 (-2.27%)

FB Facebook
$364.61 /

-8.48 (-2.27%)

Hot Stocks
Cathie Wood's ARK Investment bought 228K shares of Robinhood on Friday  06:13
09/20/21
09/20
06:13
09/20/21
06:13
HOOD

Robinhood

$42.45 /

+0.515 (+1.23%)

 
ShowHide Related Items >><<
HOOD Robinhood
$42.45 /

+0.515 (+1.23%)

HOOD Robinhood
$42.45 /

+0.515 (+1.23%)

08/23/21
Fly Intel: Top five analyst initiations
08/23/21 Rosenblatt
Robinhood initiated with a Buy at Rosenblatt
08/23/21 JPMorgan
JPMorgan starts Robinhood at Underweight, says success priced into shares
08/23/21 Deutsche Bank
Deutsche starts Robinhood at Hold despite 'exceptionally attractive' potential
HOOD Robinhood
$42.45 /

+0.515 (+1.23%)

  • 29
    Jul
HOOD Robinhood
$42.45 /

+0.515 (+1.23%)

HOOD Robinhood
$42.45 /

+0.515 (+1.23%)

HOOD Robinhood
$42.45 /

+0.515 (+1.23%)

Initiation
FinTech Acquisition Corp. V initiated with a Neutral at Compass Point » 06:12
09/20/21
09/20
06:12
09/20/21
06:12
FTCV

FinTech Acquisition Corp. V

$10.26 /

-0.02 (-0.19%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTCV FinTech Acquisition Corp. V
$10.26 /

-0.02 (-0.19%)

FTCV FinTech Acquisition Corp. V
$10.26 /

-0.02 (-0.19%)

Recommendations
Protagonist selloff on clinical hold an overreaction, says at H.C. Wainwright » 06:12
09/20/21
09/20
06:12
09/20/21
06:12
PTGX

Protagonist Therapeutics

$17.60 /

-28.53 (-61.85%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

04:42 Today JPMorgan
Protagonist Therapeutics downgraded to Neutral from Overweight at JPMorgan
09/17/21 Piper Sandler
Protagonist selloff 'overdone' following clinical hold, says Piper Sandler
09/17/21 Piper Sandler
Protagonist clinical hold brings more questions than answers, says Piper Sandler
08/06/21 H.C. Wainwright
Protagonist Therapeutics price target raised to $60 from $50 at H.C. Wainwright
PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

  • 16
    Jun
  • 11
    Dec
PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

Recommendations
Sprout Social price target raised to $150 from $110 at BTIG » 06:11
09/20/21
09/20
06:11
09/20/21
06:11
SPT

Sprout Social

$136.95 /

+1.66 (+1.23%)

BTIG analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPT Sprout Social
$136.95 /

+1.66 (+1.23%)

09/17/21 Barclays
Sprout Social price target raised to $158 from $112 at Barclays
09/07/21 Stifel
Sprout Social price target raised to $135 from $105 at Stifel
08/04/21 Canaccord
Sprout Social price target raised to $100 from $77 at Canaccord
07/23/21 Barclays
Sprout Social price target raised to $106 from $77 at Barclays
SPT Sprout Social
$136.95 /

+1.66 (+1.23%)

SPT Sprout Social
$136.95 /

+1.66 (+1.23%)

Downgrade
Top Glove downgraded to Sell from Neutral at Citi » 06:09
09/20/21
09/20
06:09
09/20/21
06:09
TGLVY

Top Glove

$3.19 /

-0.01 (-0.31%)

Citi analyst Megat Fais…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGLVY Top Glove
$3.19 /

-0.01 (-0.31%)

05/19/21 Credit Suisse
Top Glove upgraded to Outperform from Neutral at Credit Suisse
03/31/21 Credit Suisse
Top Glove downgraded to Neutral from Outperform at Credit Suisse

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.